ESSA Pharma to Present at the Oppenheimer 33rd Annual Healthcare Conference

Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on prostate cancer therapies, announced its presentation at the Oppenheimer 33rd Annual Healthcare Conference on March 15, 2023, at 11:20 a.m. Eastern Time. The event will feature David R. Parkinson, President and CEO, along with COO Peter Virsik and CFO David S. Wood, who will also participate in one-on-one meetings. Investors can access a live webcast through ESSA's website, with an archived version available for 90 days post-event. ESSA aims to develop novel therapies to improve prostate cancer treatment outcomes.

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, March 8, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the virtual Oppenheimer 33^rd Annual Healthcare Conference on Wednesday, March 15, 2023, at 11:20 a.m. Eastern Time.

David R. Parkinson, President and Chief Executive Officer of ESSA Pharma; Peter Virsik, ESSA's Chief Operating Officer; and David S. Wood, ESSA's Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the Oppenheimer presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-oppenheimer-33rd-annual-healthcare-conference-301765119.html

SOURCE ESSA Pharma Inc

FAQ

When will ESSA Pharma present at the Oppenheimer Healthcare Conference?

ESSA Pharma will present on March 15, 2023, at 11:20 a.m. Eastern Time.

Where can I watch the ESSA Pharma presentation?

The presentation can be accessed live on ESSA's website in the Investors/Events & Presentations section.

Who will represent ESSA Pharma at the conference?

David R. Parkinson, Peter Virsik, and David S. Wood will represent ESSA at the conference.

How long will the ESSA Pharma webcast be available?

The webcast will be archived on ESSA's website for 90 days after the event.

What is the focus of ESSA Pharma's research?

ESSA Pharma is focused on developing novel therapies for the treatment of prostate cancer.